Cargando…
Association between angiotensin-converting enzyme inhibitors and the risk of lung cancer: a systematic review and meta-analysis
BACKGROUND: The association between the use of angiotensin-converting enzyme inhibitors (ACEIs) and lung cancer risk remains controversial. This study evaluated the association between the use of ACEIs and lung cancer risk. METHODS: Records from five databases were searched from inception to 26 Janu...
Autores principales: | Wu, Zhenchao, Yao, Taikang, Wang, Zilu, Liu, Beibei, Wu, Nan, Lu, Ming, Shen, Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9670057/ https://www.ncbi.nlm.nih.gov/pubmed/36396817 http://dx.doi.org/10.1038/s41416-022-02029-5 |
Ejemplares similares
-
Association between angiotensin-converting enzyme inhibitor-induced cough and the risk of lung cancer: a Mendelian randomization study
por: Yao, Taikang, et al.
Publicado: (2023) -
Angiotensin converting enzyme inhibitors and risk of lung cancer: A systematic review and meta-analysis
por: Batais, Mohammed, et al.
Publicado: (2021) -
Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010) -
Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension
por: Tian, Ci, et al.
Publicado: (2021) -
Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)